Lv74
3630 积分 2023-09-02 加入
The impact of CD3 affinity-attenuation on T cell engaging bispecific antibodies: is it really that simple?
28天前
已完结
Optimising CAR-T cell sensitivity by engineering matched extracellular sizes between CAR/antigen and CD2/CD58 adhesion complexes
2个月前
已关闭
Myeloid-derived suppressor cells in cancer and cancer therapy
2个月前
已完结
Homogeneous multi-payload antibody–drug conjugates
3个月前
已完结
Treatment of Small Cell Lung Cancer with Lurbinectedin: A Review
3个月前
已完结
Safety and activity of an engineered, liver-tropic adeno-associated virus vector expressing a hyperactive Padua factor IX administered with prophylactic glucocorticoids in patients with haemophilia B: a single-centre, single-arm, phase 1, pilot trial
4个月前
已完结
BCMA-Targeted T-Cell–Engager Therapy for Autoimmune Disease
7个月前
已完结
IL-15/IL-15Rα-Fc fusion protein XmAb24306 potentiates activity of CD3 bispecific antibodies through enhancing T cell expansion
8个月前
已完结
Phase 1, first-in-human study of TYRP1-TCB (RO7293583), a novel TYRP1-targeting CD3 T-cell engager, in metastatic melanoma: active drug monitoring to assess the impact of immune response on drug exposure
8个月前
已关闭
Recent developments in the transcriptional regulation of cytolytic effector cells
8个月前
已关闭
皖公网安备34019202002308
